Anila Lingamneni, EVP, Chief Technology Officer at HAEMONETICS CORP (HAE), sold 2,305 shares at $95.00 ($219K) on 2024-05-06, disclosed to the SEC on 2024-05-08.
Scheduled sale ($219k) by EVP, Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HAE | SELL | 2023-06-01 | $384K | — | Filing → |
| HAE | SELL | 2022-05-23 | $164K | — | Filing → |
| HAE | SELL | 2022-04-19 | $11K | — | Filing → |